Risk factors and clinical expression of HCV infection in hemodialysis patients

P. Pauri, G. Salvoni, W. Vitolo, P. Carletti, E. Fanciulli, A. M. Ricciatti, S. Della Bella, V. A. Mioli

Research output: Contribution to journalArticlepeer-review

Abstract

In our Dialytic Unit, the prevalence of antibodies to HCV (anti-HCV) was 16.4% in 1990 (73 hemodialyzed) and 21% in 1991 (105 hemodialyzed). The incicidence of seroconversion was 13.1%. The transaminase behavior was similar in a group of anti-HCV-positive and a group of anti-HCV-negative patients and with previous HBV infection. Blood transfusions and dialytic age did not affect anti-HCV positivity.

Original languageEnglish
Pages (from-to)313-314
Number of pages2
JournalNephron
Volume61
Issue number3
Publication statusPublished - 1992

Keywords

  • Blood transfusion
  • Dialysis
  • HCV infection
  • Incidence
  • Prevalence
  • Transaminases

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Risk factors and clinical expression of HCV infection in hemodialysis patients'. Together they form a unique fingerprint.

Cite this